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Diabetes is the most common endocrine disease in the United States and throughout the 
world. The Center for Disease Control and Prevention (2017) estimated that 30.3 million 
Americans had diabetes in 2015, with type 2 diabetes accounting for 90% to 95% of all diabetes 
cases. The American Diabetes Association (2019) describes type 2 diabetes as a metabolic 
condition where the body does not use insulin properly, leading to insulin resistance and the 
destruction of pancreatic beta cells. Patients with type 2 diabetes, require thorough evaluations 
from their surgical team during the entire surgical process due to the risk of infections, anesthetic 
complications, and adverse recovery outcomes. This case report and literature review will 
highlight why perioperative glycemic management in type 2 diabetes patients undergoing 
surgical procedures is significant.  Proper perioperative glycemic control in an adult with type 2 
diabetes will aim at decreasing surgical infection risk, decreasing cardiovascular outcomes, 
















 The American Diabetes Association (2019) noted that about 25%-50% of diabetic 
patients would need surgery at some point in their lives compared to non-diabetic patients. 
Studies show that the number of diabetes patients will increase to about 48.3 million Americans 
by the year 2050 (Stryker, 2016). With such anticipation, clinicians must be well informed on 
how to care for these patients especially during surgery. The estimated total cost of diagnosed 
diabetes in the United States in 2017 was $327 billion, with the direct medical cost at $ 237 
billion, resulting in $90 billion in reduced productivity (ADA, 2019).  As cited above, diabetes 
has a profound impact on the patient’s quality of life as well as on the economy. 
 This case report presents a 47-year-old Caucasian female with uncontrolled type 2 
diabetes, who is diagnosed with cholelithiasis. She is being referred to general surgery for a 
cholecystectomy. Thorough assessment, referral, and coordination with diabetes patients, their 
primary care provider, endocrinologists, the patient’s diabetic and surgical team during the 
perioperative period are critical in preventing complications (Kallio et al., 2015). The patient, 
like many people with diabetes, has established significant risk factors for complications during 
and after the surgical produce; thus, requiring cares from professionals who are knowledgeable 
on proper perioperative glycemic management. According to Stryker (2016), type 2 diabetes 
patients undergoing total joint arthroplasty had increased wound complications compared to non-
diabetics. They had increased risk for perioperative and postoperative infections, deep vein 
thrombosis, increased hospital cost, prolonged length of stay, recurrent readmission, and greater 
perioperative mortality (Stryker, 2016). 
Khan, Ghali & Cagliero (2018) noted that diabetic surgical patients, in general, fall into a 
higher risk category compared to non-diabetics. These patients when compared to nondiabetic 




experience increase surgical complications associated with hypoglycemia and hyperglycemia. 
Therefore, perioperative glycemic management will require thorough evaluations to minimize 
renal, cardiovascular and neurologic complications (Khan et al., 2018). It is critical that 
clinicians have in-depth knowledge of the impact of glycemic management in type 2 diabetes 
patients and utilize a multimodality team approach in the overall care and delivery process. 
Stryker (2016) emphasized that effective communication of glycemic management goals and the 
active participation of all members involved in the patient’s care is essential to the success of a 
perioperative management glycemic outcome. This case report will examine the clinical 
significance of perioperative glycemic control in type 2 diabetic patients, critical factors that 
need to be addressed and ways to optimize patient care.  
Case Report 
Mrs. K is a pleasant 47-year-old female who presents with complaints of right upper 
quadrant abdominal pain that started 12 hours ago. The patient states "It started pretty soon after 
dinner yesterday, and it has not gone away, since yesterday evening. I think it is getting worse." 
Patient reports that her pain is located in the middle, right upper quadrant of her abdomen and 
radiates to her center back and right shoulder. She describes her pain as an 8 out of 10 and dull in 
nature. She denies having previous episodes like this. However, she reports that she has had 
some stomach pain after meals a few months back, which went away after a couple of hours 
without intervention. Interventions attempted to include, application of warm water bottle with 
no relief. The patient states that sitting hunched over or lying on her side seems to help alleviate 
the pain (5/10) while moving and lying down on her back makes the pain worse. Patient reports 
having a stable appetite and a diet consisting of high levels of fat and complex carbohydrates. 
The patient denies any recent fever, chills, diarrhea or constipation. She denies bladder or bowel 




irregularities, weight gain or loss. The patient also denies any headache, shortness of breath, 
chest pain, and musculoskeletal issues, other than right shoulder discomfort. 
Pertinent past medical history includes diabetes type 2, hypertension, and obesity. Family 
history includes cardiovascular disease on the father's side (father died of a stroke when he was 
65, and his mother has gallstones). The patient has no surgical history. Patient denies having any 
allergies. Current medications, the patient is currently prescribed Lisinopril 20mg and Metformin 
1000mg daily. Patient notified the provider that she has not been compliant with taking her 
medications. She takes her pills several times a week, depending on how she feels rather than 
prescribed. Patient’s social history includes married, lives at home with her husband, and has two 
children. She is a financial consultant. She reports drinking about 1–2 glasses of wine at dinner 
time most nights and even more when guests visit. However, the patient denies using any 
tobacco or illicit drugs. The patient does not exercise, stating she cannot find time for it. 
Physical exam was negative except for discomfort from dull pain in the middle back, 
right shoulder, tenderness in the RUQ and epigastric region with guarding. Vital signs as 
follows, T: 99.5°F BP: 186/100 HR: 102 R: 20 Oxygen sat:98% on room air, and BMI: 30 
kg/m2. Significant findings include a mildly elevated temperature and significantly elevated BP 
186/100. Lab test and imaging ordered during this patients visit includes complete blood count 
(WBC-12.4 and BS-210), comprehensive metabolic panel (Calcium-10.1), liver function test 
(AST- 420u/l and ALT-590u/l), amylase (Negative) and lipase (32), HgbA1C (8.5), alkaline 
phosphatase (137), and total bilirubin (4.1 mg/dl). Imaging includes an upright and supine 
ultrasound of the abdomen that indicated a 3mm gallstone. Patient diagnosis is cholelithiasis.  
Treatment plan includes pain management with ibuprofen 400 mg every four hours as 
needed, and a general surgery consults for cholecystectomy. Removal of the gallbladder is 




generally indicated in patients who have experienced symptoms or complications of gallstones 
(Heuman, 2017). With a history of uncontrolled hypertension and uncontrolled diabetes, this 
patient is at moderate to high risk for surgical complications. Initial treatment plan includes 
normalizing her blood pressure. The patient was ordered to take her medication as scheduled 
daily, monitor BP daily for one week, document and return to the clinic for evaluation and 
further treatment. The patient was advised to take her metformin as prescribed as well, monitor 
her blood sugar AC & HS at home daily.  She will document it and follow-up a week later for 
evaluation and further management. She was also educated on lifestyle modifications such as, 
decreasing the rate of her alcohol consumption, eating meals low in fat and cholesterol, but high 
in fiber. Patient instructed to exercise regularly, at least 150 minutes of moderate aerobic activity 
or 75 minutes of vigorous aerobic activity a week (Heuman, 2017). The patient was made aware 
of the surgical complications that are associated with uncontrolled diabetes and hypertension.  
Literature Review 
A literature review was conducted to examine the significance of perioperative glycemic 
management in type 2 diabetes patients. An in-depth search of current literature was performed 
using the University of North Dakota's Harley E. French Library of Health Sciences. PubMed 
was one of the online databases used to conduct a systematic search of literature with a keyword 
search using MeSH terms Perioperative AND glycemic management AND type 2 diabetes. 
Other MeSH terms using PubMed include Preoperative AND glycemic management AND 
diabetes, and Postoperative AND glycemic control AND diabetes AND outcome within the last 
five years. The search yielded more than 45 articles and I choose18 of the articles relevant to my 
topic of discussion. 




According to the Center for Disease Control and Prevention (2017), an estimated 30.3 
million or more Americans have diabetes. About 48.3 million Americans are projected to have 
diabetes by 2050 (Stryker, 2016).  About 25% of patients with diabetes will undergo surgery at 
some point in their life (Jehan et al., 2018). These statistics are critical for clinicians as diabetic 
patients account for a significant proportion of primary care visits, and as indicated will need 
surgery at some point in their life. People with diabetes have a higher perioperative risk for 
surgical complications, metabolic alterations, and longer hospital stays, compared to the non-
diabetic population (Boreland, Scott-Hudson, Hetherington, Frussinetty, and Slyer, 2015). 
Physiological changes during the surgical procedure and complications resulting from 
hypo/hyperglycemic episodes can pose challenges for clinicians caring for these patients. 
Therefore, it is essential to conduct thorough preoperative evaluations, utilize evidence base 
glycemic management strategies in the perioperative period, and appropriate postoperative 
glycemic interventions to prevent or minimize adverse outcomes. 
Why Manage Glucose Levels in the Surgical Setting? 
Diabetes affects multiple organs of the body leading to microvascular and macrovascular 
complications. These complications are a significant contributor to mortality and morbidity in 
diabetic patients, especially in a surgical situation. Diabetic patients as noted earlier will require 
a surgical procedure and are more likely to have adverse perioperative events compared with 
nondiabetic patients. Studies show that poor perioperative glycemic control is associated with 
poor surgical outcomes. Furthermore, the length of hospital stay for diabetes patients is 45% 
higher than those without diabetes, and mortality of surgical patients is twice as high as those 
without diabetes (Dhatariya, Levy, and Hall, 2016).  Early identification of patients with poorly 
controlled diabetes in the preoperative period, will initiate communication between the clinical 




teams and enable proactive treatment during the various stages of surgery. Glycemic 
management will minimize error, improve their glycemic control, and lower the risk of surgical 
complications. 
Stress associated with surgery is also known to counter-regulate the bodies hormone 
levels leading to an increase in glucose concentrations and hyperglycemia. Jehan et al. (2018) 
noted that hyperglycemia places diabetic patients at an increased risk for cerebral ischemia, 
impaired wound healing, and prolonged hospital stays. In addition to these complications, the 
stress response from surgery may also cause other diabetic pathologies such as diabetic 
ketoacidosis or hyperglycemic hyperosmolar syndrome during surgery or postoperatively (Jehan 
et al., 2018).  
Diabetic patients also experience hypoglycemia, which is a known independent risk 
factor that is associated with increased mortality. Thompson, Stearns, Apsey, Schlinkert, and 
Cook (2016) reported that during the perioperative period, recognizing the neurological 
manifestations of hypoglycemia when a patient has been under general anesthesia can be 
difficult thus, exposing the individual to a prolonged hypoglycemic state and increase adverse 
outcomes. Sreedharan and Abdelmalak (2018) agreed that providers should worry about 
perioperative glycemic states in a diabetic patient because hypoglycemia sometimes masked 
under general anesthesia resulting in irreversible neurologic damage and adverse perioperative 
outcomes. 
In addition to recognizing the above complications, studies have shown that diabetic 
patients with well-control glucose levels undergoing major surgery such as cardiac and 
orthopedic, experienced decreased adverse surgical complications (Sreedharan and Abdelmalak, 
2018). Therefore, clinicians need to be vigilant and accurately identify diabetic patients at risk to 




prevent adverse outcomes and co-morbidities. It is critical that clinicians view the perioperative 
glycemic management in a type 2 diabetes patient as a continuum of care starting with admission 
through discharge.   
Preoperative Glycemic Evaluation 
The American Diabetes Association (2018) recommends that clinicians perform a 
preoperative risk assessment for diabetes patients at high risk for ischemic disease, autonomic 
neuropathy or renal failure (p. S148). The Society for Ambulatory Anesthesia has published 
guidelines for perioperative management of diabetic patients undergoing ambulatory surgery. 
They also recommend that providers perform a thorough evaluation of the patient’s preoperative 
glycemic level, assess history and risk for hypoglycemia, the timing of operation and duration of 
fasting required before the initiation of preoperative insulin treatment (Demma, Carlson, 
Duggan, Morrow and Umpierrez, 2017).  
With preoperative evaluations, clinicians will identify diabetic patient’s risk factors and 
initiate early glycemic management. This phase will provide opportunities for early referrals and 
consultations, patient education, and medication reconciliation. Khan et al. (2018) emphasized 
that clinicians use the preoperative phase for “testing and laboratory evaluations that include 
basal glucose level, an electrocardiogram assessing cardiac risk, comprehensive chemistry panel 
to assess renal function, complete blood count, and hemoglobin A1c” (p.2). They emphasized 
that asymptomatic diabetic patients with cardiac risk factors including hypertension, tobacco use, 
and a family history of cardiovascular disease, should undergo cardiac image or stress testing to 
rule out coronary artery disease before general anesthesia use. This is because an EKG alone 
might not be sufficient to diagnose silent coronary artery disease known to cause complications 
with anesthesia use (Khan et al., 2018, p.2).  




Miller & Richman (2016) noted that Hollenberg and colleagues in their study reported 
diabetes as one of the five independent risk factors for postoperative myocardial ischemia. They 
indicated that insulin-dependent diabetes is one of the five clinical risk factors on the Revised 
Cardiac Risk Index used for assessing major cardiac complications, such as cardiac arrest, 
myocardial infarction, heart failure, and heart block. This preoperative assessment of cardiac risk 
is done according to the American College of Cardiology/American Heart Association guidelines 
(Miller & Richman, 2016, p.157). 
  Clinicians must also evaluate and manage glycemic control in patients utilizing oral 
glycemic agents before surgery. The American Association of Clinical Endocrinologists and the 
American Diabetes Association recommended that surgical patients on oral diabetes should be 
identified and instructed to hold their metformin for 24 hours before surgery due to risk for renal 
impairment, hemodynamic instability, and the development of lactic acidosis (Miller & 
Richman, 2016, p.160). A randomized control study by Hulst et al. (2018) supported that finding. 
They found that a continuation of metformin during the perioperative period did not affect 
perioperative glycemic control other than a slight increase in the plasma lactate level. However, 
the rise in plasma lactate level was not significant to determine whether or not metformin should 
be continued or held during surgery (Hulst et al., 2018). Clinicians must be aware of these 
recommendations since not all diabetic patients utilize insulin therapy.  
Preoperative evaluation of glycosylated hemoglobin (HbA1c) is crucial in preventing 
surgical complications. A retrospective observational study was conducted by Kallio et al. (2015) 
evaluating the impact of preoperative clinic referral by anesthesia for elevated HbA1c in patients 
undergoing total joint arthroplasty. The results of their study showed that patients undergoing 
JTA with uncontrolled HbA1c (great than10%) had a higher incidence of coronary artery 




disease, hypercholesterolemia, and increased surgical complication rates compared to those with 
HbA1c of less than 8% or without DM (Kallio et al., 2015). The study also saw a 10% increase 
in prolonged hospital stays for DM patients with uncontrolled HbA1c, compared to those without 
DM (Kallio et al., 2015).   
A meta-analysis study Yang, Sun, Li, and Liu (2017) assessing whether hemoglobin A1c 
and perioperative hyperglycemia was associated with increased risk of periprosthetic joint 
infection in diabetes patients undergoing a total knee and hip arthroplasty also showed that high 
HbA1c (greater than 7)  and perioperative hyperglycemia are associated with a higher risk of 
periprosthetic joint infections. These studies highlight the importance of preoperative HbA1c 
evaluations and management before surgery. They emphasized that HbA1c is beneficial in 
classifying perioperative risk in diabetic patients. Therefore, clinicians should use the HbA1c 
levels to determine the glycemic management needs of surgical diabetes patients and initiate 
prompt treatment needed to prevent or reduce adverse surgical outcomes. An appropriate 
preoperative glycemic management plan will help clinicians avoid both hypoglycemia and 
hyperglycemia on the day of surgery, and postoperatively. 
 Glycemic Management During the Perioperative Period 
With diabetes, patients are at increased risk of mortality and postoperative complications 
compared to non-diabetics. Thus, clinicians must adequately manage glucose levels during the 
perioperative period. To prevent surgical risk and reduce complications, Blaha et al. (2015) 
emphasized that clinicians have a clear understanding of glycemic strategies used in optimizing 
glycemic control. These strategies will guide providers and assure their patients’ safety. 
However, the consensus regarding glycemic goal and management strategies proposed to 




maintain optimal glucose levels perioperatively has been difficult to establish due to study data 
inconsistency (Blaha et al., 2015, p.3082). 
Khan et al. (2018) also agreed that perioperative glucose targets and protocols vary with 
little supportive evidence. They noted that the decision on which strategies to use depends on the 
individual hospital or providers. A metanalysis of 12 randomized trials evaluating intensive 
(<120 or <150mg/dl) versus conventional glycemic control during the perioperative period 
reported that intensive glycemic control perioperatively was not associated with any reduction in 
infectious complications, cardiovascular events or mortality. However, it was associated with an 
increased risk for hypoglycemia (Khan et al., 2018). Palermo & Garg (2019), in their study, 
agreed that tight glycemic control during the intraoperative period failed to show a significant 
clinical outcome as well. They reported that variation in insulin infusion during the perioperative 
period was considered the safe and most effective means to achieve glycemic control and prevent 
adverse outcomes, and not implementation tight glycemic control.  As cited in these studies, the 
use of tight glycemic control would result in a higher risk for hypoglycemia and surgical 
complications — an essential assessment for clinicians to consider during the perioperative phase 
of surgery. 
Khan et al. (2018) also suggested that, for short procedures lasting less than two hours, 
diabetic patients utilizing insulin can continue subcutaneous insulin perioperatively, rather than 
an insulin infusion. They recommended that these patients should also delay taking their morning 
insulin until after surgery, and before they eat when scheduled for morning procedures. Khan et 
al. (2018) emphasized that diabetic patients who are on continuous insulin pumps may continue 
their basal insulin without any changes to their regular regiment, given that their basal insulin 
dose can be calculated correctly to meet the needs of surgery. 




Khan et al. (2018) stressed that IV insulin is required long, complex procedures lasting 
greater than two hours to achieve appropriate glycemic control. They reported that studies have 
compared the use of subcutaneous insulin versus IV infusion and found a significant increase in 
the variability of the glucose concentration when using the subcutaneous route. Therefore, not 
only are insulin infusions in monitored settings are safe, it can be titrated to enabling more 
precise glucose control. Khan et al. (2018) recommended that blood glucose should be monitored 
every hour and more frequently in patients using IV insulin infusion. The preferred method for 
intraoperative glucose testing is by laboratory or point of care testing and not finger stick 
because they are less reliable. If hypoglycemia occurs or blood glucose levels drop to100mg/dl 
or less, insulin infusion should not be stopped but reduced to maintain appropriate glucose 
targets (Khan et al., 2018). 
    A systematic protocol with simple and clear directions must also be in place to achieve 
safe and reasonable levels of glycemic controls in hospitalized diabetic patients. These protocols 
will facilitate a successful glycemic transition throughout every stage of surgery, produce 
positive outcomes, and reduce cost.  For instance, the 17-year prospective Portland Diabetes 
Project, a non-randomized study of diabetes patients who underwent open-heart surgery with 
implementation of an IV insulin infusion, resulted in a 66% reduction of postoperative deep 
sternal wound infections and a total net savings to the hospital of $4,638 per patient (Miller & 
Richman, 2016). This study emphasizes the importance of having a glycemic protocol when 
caring for diabetic patients undergoing surgery and its impact on the economy. 
The concept of tight glycemic control in diabetes patient has been called into question 
whether or not it impacts the patient's surgical outcomes. The American Diabetes Association 
(2018) report on diabetes care in hospitals, recommends that clinicians initiate insulin therapy for 




persistent hyperglycemia with blood sugars levels above 180mg/dl with a target range of 140-
180 mg/dl for critically ill and non-critically ill diabetic patients. The ADA (2018) also 
suggested that strict glycemic target of 110-140mg/dl may be utilized for some critically ill 
patients as long as clinicians can prevent hypoglycemia.   
The ADA (2018) also emphasized that hospitals adopt and implement a hypoglycemic 
management protocol with an individualized plan to prevent hypoglycemia. Their 
recommendations include maintaining perioperative target glucose of 80-180mg/dl vs. tighter 
glucose control known to result in hypoglycemia and adverse surgical outcomes. An 
observational study on the effect of basal insulin dosage on blood glucose concentration in 
ambulatory surgery patients with type 2 diabetes by Demma et al. (2017) observed that, patients 
who reduced their evening basal insulin dose by 25 % the evening prior to surgery, achieved 
target glucose control on the day of operation compared to patients who took their full insulin 
dose. With IV insulin infusion proven to be the best method for achieving glycemic targets in the 
perioperative period, a well- written protocol based on evidence will allow for predefined 
adjustments in patients infusion rates, proper management of glycemic fluctuations, and reduce 
complications. It is imperative that future studies work on consensus guidelines or standardize 
protocols for optimal perioperative glycemic control of patients with diabetes undergoing 
surgery.  
Postoperative Glycemic Management and Outcome 
Postoperative glycemic management is critical as patients transition from inpatient to 
outpatient care. Postoperative glycemic control will maintain a safe glucose target range and 
prevent complications that could either delay patients discharge or impair healing and recovery. 
Hypoglycemia or hyperglycemia before, during and after surgery is known to complicate the 




recovery process. Hyperglycemia during surgery has been associated with a 30% increase in 
adverse surgical outcomes such as increase in surgical site infections, pulmonary and renal 
complications (Thompson et al., 2016). Diligent blood glucose management during the 
perioperative period will minimize the risk of postoperative complications and enhance the 
recovery process.   
To avoid postoperative adverse outcomes in diabetic patients, Khan et al. (2018) 
recommended that diabetes treatment regimen before surgery be reinstated once the patients start 
eating. They emphasized that diabetes patient should receive their first dose of subcutaneous 
insulin before discontinuation of the IV insulin infusion due to its short half-life, and the risk for 
hypoglycemia in the postoperative phase (Khan et al., 2018). As noted earlier, clinicians must 
avoid hypoglycemia during anesthesia use because hypoglycemic symptoms may mimic post-
anesthesia symptoms in the postoperative stage. To optimize glucose control, a sedated and 
anesthetized patient with a blood glucose of <70 mg/dl should be given IV dextrose (25 g) 
immediately, and blood glucose measurements repeated every 10 minutes until the stability of 
the glucose level is achieved (Khan et al., 2018). 
  The study by Jehan et al. (2018) evaluating the impact of HbA1c levels on outcomes after 
general emergency surgery found that patients with hypertension, history of coronary artery 
disease, body mass index of 30 kg/m or higher, and a HbA1c of 6.0% or greater experienced 
significant surgical complications. These patients stayed in the hospital an average of four days 
longer than their counterparts, had a 16% increase in complication rates, and a 30-day 
readmission rate of 8% compared to 3.2% in those with less than 6% HbA1c (Jehan et al., 2018).  
As indicated in the literature, a HbA1c must be assessed in all diabetes patients before surgery, 
and interventions initiated to prevent complications and promote recovery. 




 A successful perioperative glycemic management requires the active participation of all 
interdisciplinary members involved in the inpatient’s care as well as the patient (Stryker,2016). 
Therefore, clinicians must educate and encourage patients to take charge of managing their blood 
glucose levels and maintain an appropriate HbA1c level to prevent co-morbidities and surgical 
complications.  
According to the ADA (2018), structured discharge plans tailored to the individual 
patients has also shown to reduce surgical complications and increase patient satisfaction.  The 
ADA (2018) recommends that diabetic patients who experienced glycemic instability in the 
hospital should follow-up with their primary care provider or endocrinology team within a one 
month for evaluation and further treatment. For patients whose glucose level are not well-
controlled at the time of discharge, they should follow-up in one to two weeks to avoid 
hyperglycemic or hypoglycemic complications (ADA, 2018). These visits will provide 
opportunities for clinicians to assess the patient’s progress, establish treatment goals, provide 
needed treatments, and assurance of continuity of care. 
Learning Points 
1. It is estimated that 25%-50% of diabetic patients will need surgery at some point in their 
lives compared to non-diabetics. Not only does diabetes impact the patient’s quality of 
life, but it is also a financial burden costing the US economy billions of dollars yearly.  
2. Preoperative evaluations are essential in diabetic patients needing surgery. Providers will 
use this stage to identify risk factors that if missed, can lead to adverse surgical outcomes, 
reconcile the patient’s medications, and manage to present health problems. 




3. A secure glycemic management protocol, not tight glycemic control during the 
perioperative period have resulted in fewer surgical complications, reduced length of 
hospital stays, decrease cost and reduce mortality. 
4. Communication between the interdisciplinary surgical team, diabetic management, and 
outpatient providers is critical in accomplishing a proper surgical glycemic control. 
Efficient communication will ease the transition from inpatient to outpatient and prevent 
adverse surgical outcomes in diabetic patients. 
5. Individualized discharge planning is a critical part of the postoperative glycemic 
management process because patients’ recoveries vary, and poor glycemic control may 
complicate their recovery process. To prevent post-surgical complications, these patients 
must be an active participant in their discharge planning and follow-up as scheduled to 
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